Real-World Clinical and Cardio-Renal Outcomes with Dapagliflozin in Type 2 Diabetes: Evidence from Southern India
Crossref DOI link: https://doi.org/10.30574/wjarr.2026.29.2.0226
Published Online: 2026-02-28
Update policy: https://doi.org/10.30574/wjarr.ourcrossmarkpolicy
Vernekar, Ritesh
N, Jagadesan
S, Praveen
Chickmath, Renuprasad
Belsare, Kiran
